A Randomized, Double-Blind, Placebo-Controlled Study of Quetiapine SR and Divalproex Sodium ER [valproate semisodium] on Anxiety in Bipolar Disorder With at Least Moderately Severe Current Anxiety and Lifetime Panic or Generalized Anxiety Disorder.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Study of Quetiapine SR and Divalproex Sodium ER [valproate semisodium] on Anxiety in Bipolar Disorder With at Least Moderately Severe Current Anxiety and Lifetime Panic or Generalized Anxiety Disorder.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 15 Feb 2013

At a glance

  • Drugs Quetiapine (Primary) ; Valproate semisodium
  • Indications Bipolar I disorders; Bipolar II disorders; Generalised anxiety disorder; Panic disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Feb 2013 Results published in the Journal of Affective Disorders.
    • 13 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 08 Feb 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top